A life-sustaining single dose of recombinant activated factor VII for an Egyptian patient with hemorrhagic crisis.
Badra
Gamal
G
Department of Hepatology, National Liver Institute, Minufiya University, Minufiya, Egypt.
El-Abassy
Mohamed
M
Lotfy
Mahmoud
M
Alenzi
Faris Q
FQ
Waked
Imam
I
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D004008:Diclofenac / Q000009:adverse effects; D015942:Factor VIIa / Q000008:administration & dosage*; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011994:Recombinant Proteins; D004008:Diclofenac; D015942:Factor VIIa